The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
From BugSigDB
Study information
study design
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
Authors
Jin Y, Dong H, Xia L, Yang Y, Zhu Y, Shen Y, Zheng H, Yao C, Wang Y, Lu S
Journal
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Year
2019
Keywords:
Advanced NSCLC, Clinical benefit, Gut microbiota, Nivolumab, Systemic immune signatures